Abstract:The devastating impact of Coronavirus Disease 2019 (COVID-19) on human health globally has prompted extensive discussions on how to better prepare for and safeguard against the next pandemic. Zoonotic spillover of pathogens from animals to humans is recognized as the predominant cause of emerging infectious diseases and as the primary cause of recent pandemics [1]. This spillover risk is increased by a range of factors (called drivers) that impact the nature, frequency, and intensity of contact between humans and wild animals. Many of these drivers are related to human impact, for example, deforestation and changes in land use and agricultural practices. While it is clear that the triad of prevention-preparedness-response (P-P-R) is highly relevant, there is much discussion on which of these 3 strategic activities in the field of emerging infectious disease should be prioritized and how to optimally target resources. For this, it is important to understand the scope of the respective activity and the consequences of prioritization. Already, the World Bank Pandemic Fund and forthcoming global Pandemic instrument [2] negotiated by the World Health Organization (WHO) [3] appear primarily focused on the early detection, and reaction to the appearance of human illnesses, often with explicit focus only on action to be taken once pathogen spillover and spread have occurred. Strategies to reduce the probability of spillover events are under-prioritized and underutilized, as highlighted by recent infectious disease crises such as Ebola and Mpox epidemics, and have been lost in overall preparedness discussions and recovery financing. This "more of the same" focus suggests that it is politically more expedient to allocate financial resources to deal with a problem once it has arisen, rather than taking the steps necessary to reduce the risk of it occurring in the first place. It is often claimed that allocating resources to prevent something from happening is politically difficult as the value of prevention is largely "invisible" (prevention paradox) or it will take a long time to show effects. However, there are now several communications highlighting the economic benefits of prevention of spillover [1,4,5]. If taken, actions to prevent spillover are estimated at 4 billion per year in social benefits from reduced greenhouse gas emissions [4]. COVID-19 has demonstrated the immense burden of a pandemic, including significant mortality resulting in economic recession, with the global economy contracting by 4.4 percent in 2020. The expected economic losses from this pandemic are estimated at nearly 52 billion; the Ebola virus disease outbreak in West Africa in 2014 to 2016 with a GDP loss of 53.19 billion [8]; and the 2015 to 2016 Zika virus disease outbreak with an estimated loss in the United States, Caribbean, and Latin America of $20 billion [9,10]. If invested in, prevention strategies would reduce the likelihood of another pandemic substantially and likely generate sufficient return on investment over time while also having the potential to generate substantial co-benefits [1,10]. Prevention is already valued in other sectors: policymakers and industries have led on prevention in other areas, such as expenditure on counter-terrorism, driving laws and insurance incentives to reduce the frequency of traffic accidents, on the nuclear deterrent, and in some cases on flood prevention and other water management measures, exemplifying a political willingness to spend vast sums of money to preempt a harmful event in certain areas or circumstances, but not on pandemic prevention.

Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report

Pandemic origins and a One Health approach to preparedness and prevention: Solutions based on SARS-CoV-2 and other RNA viruses

Post COVID-19: a solution scan of options for preventing future zoonotic epidemics

Conference Report: LPMHealthcare Emerging Viruses 2023 (EVOX23): Pandemics-Learning from the Past and Present to Prepare for the Future

Ecological countermeasures to prevent pathogen spillover and subsequent pandemics

Progress in vaccine development for infectious diseases—a Keystone Symposia report

Respiratory viruses: New frontiers-a Keystone Symposia report

Prevention of zoonotic spillover: From relying on response to reducing the risk at source

Applying lessons of COVID-19 and other emerging infectious diseases to future outbreaks

We need a global framework for promoting safe handling of high consequence pathogens

Emerging zoonoses: the challenge for public health and biodefense

Pandemic-Proofing: Intercepting Zoonotic Spillover Events

Ranking the risk of animal-to-human spillover for newly discovered viruses

Mitigating Future Respiratory Virus Pandemics: New Threats and Approaches to Consider

Zoonotic spillover and viral mutations from low and middle-income countries: improving prevention strategies and bridging policy gaps

Modern technologies and solutions to enhance surveillance and response systems for emerging zoonotic diseases

Implications of Zoonoses From Hunting and Use of Wildlife in North American Arctic and Boreal Biomes: Pandemic Potential, Monitoring, and Mitigation

Vaccine Preventable Zoonotic Diseases: Challenges and Opportunities for Public Health Progress

Pandemics Throughout History

Synergistic fight against future pandemics: Lessons from previous pandemics

Pandemic preparedness: On the efficacy of non‐pharmaceutical interventions in COVID‐19 and about approaches to predict future pandemic viruses